LGG-12. SAFETY AND EFFICACY OF DUAL THERAPY WITH DABRAFENIB AND TRAMETINIB IN AN INFANT WITH BRAF V600E MUTANT INOPERABLE LOW GRADE GLIOMA

OBJECTIVE: To describe safety and efficacy of dual targeted therapy with dabrafenib (BRAFi) and trametinib (MEKi) in an infant with inoperable low grade glioma with BRAF V600E mutation. INTRODUCTION: Safety and efficacy of dual targeted therapy with BRAFi and MEKi for pediatric low grade glioma (pLG...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Green, Sage, Walter, Andrew, Piatt, Joseph, Kaur, Gurcharanjeet
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2021
Teme:
Low Grade Gliomas
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8168189/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noab090.136
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki